Strategies include starting with a low dose and gradually increasing it, making dietary changes, staying hydrated, and in some cases, prescribing anti-nausea medications
Demonstrates broad regenerative potential across multiple tissue types including skin, hair, and bone
Patients with a history of skin disorders or those taking medications that increase photosensitivity should avoid direct sunlight and use sun protection
Cardiovascular and kidney protective benefits likely decrease
The commercial game for positions 2 through 5 in the triple-agonist category is not "match Retatrutide's 28.7%." It is "deliver 20-24% at a materially lower price, with a better tolerability profile, or via an oral formulation that improves compliance." 5.4 The Dysesthesia Signal and What It Implies Mechanistically Retatrutide's TRIUMPH-4 readout reported dysesthesia - abnormal sensory nerve sensations including tingling, burning, or reduced sensation - at 8% on the 9 mg arm and 20.9% on the 12 mg arm